AT1 2.44% 2.0¢ atomo diagnostics limited

AT1 FY21 - General Discussion + FA, page-2171

  1. 1,096 Posts.
    lightbulb Created with Sketch. 66
    Rant warning: The big risk is that they can't take advantage of the opportunity because of poor management.

    It's ridiculous that a company with this much experience in self-testing cannot still, even now, two years into a pandemic, get their self-test approved.
    Now, I understand fully that because of spot pricing self-testing would have not been THAT profitable anyway. But it's a litmus test for this company on delivering outcomes and they have failed in that. It's hugely disappointing.

    I suggest everyone keep snippets of his claims and hold them up to the light next AGM.

    For me, Kelly claimed self-testing would go 'gangbusters' in the US and I specifically remember he used that world.
    Sure, fine but can this company take any advantage out of it?
    The one I am worried about is this plastic swab test attachment. It was conceived in a hurry and I haven't seen any evidence for its existence.




    Last edited by buildabridge: 06/07/22
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
-0.001(2.44%)
Mkt cap ! $12.78M
Open High Low Value Volume
2.0¢ 2.0¢ 2.0¢ $626 31.30K

Buyers (Bids)

No. Vol. Price($)
7 863999 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 152000 2
View Market Depth
Last trade - 15.43pm 10/09/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.